Samlyn Capital LLC lessened its position in Humana Inc. (NYSE:HUM) by 77.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 44,668 shares of the insurance provider’s stock after selling 151,534 shares during the quarter. Samlyn Capital LLC’s holdings in Humana were worth $10,748,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the stock. Acrospire Investment Management LLC purchased a new position in Humana in the 2nd quarter valued at approximately $120,000. Independent Portfolio Consultants Inc. grew its stake in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after acquiring an additional 94 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of Humana by 139.5% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after acquiring an additional 325 shares in the last quarter. Fiduciary Trust Co. acquired a new position in shares of Humana in the second quarter worth $135,000. Finally, Guardian Life Insurance Co. of America grew its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after acquiring an additional 4 shares in the last quarter. Hedge funds and other institutional investors own 95.12% of the company’s stock.

In other news, insider William Kevin Fleming sold 3,071 shares of the stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $250.98, for a total transaction of $770,759.58. Following the transaction, the insider now owns 7,681 shares of the company’s stock, valued at $1,927,777.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bruce D. Broussard sold 12,000 shares of the stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the transaction, the chief executive officer now directly owns 80,086 shares in the company, valued at approximately $20,172,061.68. The disclosure for this sale can be found here. Over the last three months, insiders have sold 55,595 shares of company stock valued at $14,133,706. 0.80% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: This report was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.thecerbatgem.com/2017/10/04/humana-inc-hum-shares-sold-by-samlyn-capital-llc.html.

A number of research firms recently issued reports on HUM. UBS AG reiterated a “neutral” rating and issued a $237.00 target price (up from $205.00) on shares of Humana in a report on Wednesday, June 28th. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a research note on Wednesday, August 23rd. Morgan Stanley upped their price target on Humana from $269.00 to $276.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Zacks Investment Research downgraded Humana from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $223.00 price target (up previously from $200.00) on shares of Humana in a report on Thursday, August 3rd. Nine research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $247.50.

Humana Inc. (HUM) traded down 0.19% on Wednesday, reaching $246.93. The company had a trading volume of 170,660 shares. The firm has a market capitalization of $35.69 billion, a PE ratio of 20.31 and a beta of 0.86. The stock has a 50 day moving average of $249.18 and a 200 day moving average of $233.91. Humana Inc. has a 12 month low of $163.50 and a 12 month high of $259.76.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The firm had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. During the same period in the prior year, the company posted $2.30 earnings per share. On average, analysts anticipate that Humana Inc. will post $11.55 EPS for the current year.

The business also recently disclosed a dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 29th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio is currently 13.06%.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.